News and Views
Clinical Pharmacology & Therapeutics (2007) 81, 153–155. doi:10.1038/sj.clpt.6100088
Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation
C Wilson1, S Schulz1 and S A Waldman1
1Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Correspondence: SA Waldman, (scott.waldman@jefferson.edu)
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Integrating Molecular Medicine into the US Health-care System: Opportunities, Barriers, and Policy ChallengesClinical Pharmacology & Therapeutics Article Response
Integrating Molecular Medicine into the US Health-care System: Opportunities, Barriers, and Policy ChallengesClinical Pharmacology & Therapeutics Article Response
